IHT Wealth Management’s CASI Pharmaceuticals CASI Stock Holding History

IHT Wealth Management’s Portfolio CASI Stock Details CASI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2,600	Closed	-$65K	–	664
2020 Q2	$65K	Buy	2,600 +200	+8%	+$4.35K	0.01%	568
2020 Q1	$49K	Sell	2,400 -600	-20%	-$14.3K	0.01%	534
2019 Q4	$93K	Hold	3,000	–	–	0.01%	598
2019 Q3	$100K	Hold	3,000	–	–	0.01%	585
2019 Q2	$96K	Buy	3,000 +127	+4%	+$4.05K	0.01%	523
2019 Q1	$82K	Buy	2,873 +500	+21%	+$17.4K	0.01%	493
2018 Q4	$95K	Buy	2,373 +1,300	+121%	+$49.2K	0.02%	453
2018 Q3	$50K	Buy	+1,073	New	+$74.9K	0.01%	420
2018 Q2	–	Sell	-700	Closed	-$30K	–	555
2018 Q1	$30K	Hold	700	–	–	0.01%	841
2017 Q4	$25K	Buy	+700	New	+$19K	0.01%	914

Other funds holding CASI

IACGFIA

IDG-Accel China Growth Fund III Associates Hong Kong $31.2M AUM 2.97% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

WSC

Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return

WSCM

Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

IHT Wealth Management's CASI Position: Q3 2020 in Review

IHT Wealth Management sold out of CASI Pharmaceuticals (CASI) in Q3 2020, closing a stake of 2,600 shares — an estimated $65K sold.

IHT Wealth Management first reported a position in CASI in Q4 2017 and held it in 10 quarters. The position peaked at $100K in Q3 2019. 67 funds tracked by Wall St. Rank hold CASI as of Q3 2020.

IHT Wealth Management reported no remaining CASI Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
IHT Wealth Management sold 2,600 CASI Pharmaceuticals shares in Q3 2020, an estimated $65K.
IHT Wealth Management first reported a position in CASI Pharmaceuticals in Q4 2017 and held it in 10 quarters.
IHT Wealth Management's CASI Pharmaceuticals position peaked at $100K in Q3 2019.
67 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q3 2020.

Based on IHT Wealth Management's 13F filing for Q3 2020, filed 19 Nov 2020.